Outcome of local failures after oral cancer - Recurrence vs. second primary

Journal of Oral Pathology and Medicine

Volumn 39, Issue 9, 2010, Pages 657-661

  Rennemo, Erlend ^a   Zätterström, Ulf ^a   Boysen, Morten ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

head and neck cancer; local recurrence; oral cancer; prognosis; second field tumor; second primary tumor; squamous cell carcinoma; survival; treatment

Indexed keywords

ADULT; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; COHORT ANALYSIS; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; MULTIMODALITY CANCER THERAPY; OBSERVATIONAL STUDY; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; RECURRENT CANCER; SECOND CANCER; SQUAMOUS CELL CARCINOMA; TREATMENT FAILURE;

CARCINOMA, SQUAMOUS CELL; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; FEMALE; HUMANS; LARYNGEAL NEOPLASMS; LIFE TABLES; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; PHARYNGEAL NEOPLASMS; PROGNOSIS; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TREATMENT FAILURE;

EID: 77957570147     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2010.00905.x     Document Type: Article

References (23)

1. Merkx MA, Gulick JJ, Marres HA. Effectiveness of routine follow-up of patients treated for T1-2N0 oral squamous cell carcinomas of the floor of mouth and tongue. Head Neck 2006 28 : 1 7.
2. Sessions DG, Spector GJ, Lenox J, Haughey B, Chao C, Marks J. Analysis of treatment results for oral tongue cancer. Laryngoscope 2002 112 : 616 625.
3. Slaughter DP, Southwick HW, Smejkal W. "Field cancerization" in oral stratified squamous epithelium. Clinical implications of multicentric origin. Cancer 1953 6 : 963 968.
4. Warren S, Gates O. Multiple primary malignant tumors: a survey of the literature and a statistical study. Am J Cancer 1932 16 : 1358 1414.
5. Gath HJ, Brakenhoff RH. Minimal residual disease in head and neck cancer. Cancer Metastasis Rev 1999 18 : 109 126.
6. Braakhuis BJ, Tabor MP, Leemans CR, van der Waal I, Snow GB, Brakenhoff RH. Second primary tumors and field cancerization in oral and oropharyngeal cancer: molecular techniques provide new insights and definitions. Head Neck 2002 24 : 198 206.
7. Tabor MP, Brakenhoff RH, Ruijter-Schippers HJ, Kummer JA, Leemans CR, Braakhuis BJ. Genetically altered fields as origin of locally recurrent head and neck cancer: a retrospective study. Clin Cancer Res 2004 10 : 3607 3613.
8. Tabor MP, Brakenhoff RH, Ruijter-Schippers HJ. Multiple head and neck tumors frequently originate from a single preneoplastic lesion. Am J Pathol 2002 161 : 1051 1060.
9. Sobin LH, Wittekind C. TNM classification of malignant tumours, 6th edn. Hoboken, NJ : John Wiley & Sons, 2002.
10. Lin K, Patel SG, Chu PY. Second primary malignancy of the aerodigestive tract in patients treated for cancer of the oral cavity and larynx. Head Neck 2005 27 : 1042 1048.
11. Califano J, Westra WH, Meininger G, Corio R, Koch WM, Sidransky D. Genetic progression and clonal relationship of recurrent premalignant head and neck lesions. Clin Cancer Res 2000 6 : 347 352.
12. Klinge U, Fiebeler A. Analysis of survival curve configuration is relevant for determining pathogenesis and causation. Med Hypotheses 2009 72 : 510 517.
13. Aguirre-Ghiso JA. Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer 2007 7 : 834 846.
14. Udagawa T. Tumor dormancy of primary and secondary cancers. APMIS 2008 8 : 615 628.
15. Bedi GC, Westra WH, Gabrielson E, Koch W, Sidransky D. Multiple head and neck tumors: evidence for a common clonal origin. Cancer Res 1996 56 : 2484 2487.
16. Braakhuis BJ, Leemans CR, Brakenhoff RH. Expanding fields of genetically altered cells in head and neck squamous carcinogenesis. Semin Cancer Biol 2005 15 : 113 120.
17. Wu X, Gu J, Dong Q. Joint effect of mutagen sensitivity and insulin-like growth factors in predicting the risk of developing secondary primary tumors and tumor recurrence in patients with head and neck cancer. Clin Cancer Res 2006 12 : 7194 7201.
18. Leon X, del Prado Venegas M, Orus C, Lopez M, Garcia J, Quer M. Influence of the persistence of tobacco and alcohol use in the appearance of second neoplasm in patients with a head and neck cancer. A case-control study. Cancer Causes Control, 2009 20 : 645 652.
19. Chuang SC, Scelo G, Tonita JM. Risk of second primary cancer among patients with head and neck cancers: a pooled analysis of 13 cancer registries. Int J Cancer 2008 123 : 2390 2396.
20. Khuri FR, Lee JJ, Lippman SM. Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients. J Natl Cancer Inst 2006 98 : 441 450.
21. Wang F, Arun P, Friedman J, Chen Z, Van Waes C. Current and potential inflammation targeted therapies in head and neck cancer. Curr Opin Pharmacol 2009 9 : 389 395.
22. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature, 2008 454 : 436 444.
23. Campisi G, Giovannelli L. Controversies surrounding human papilloma virus infection, head &neck vs oral cancer, implications for prophylaxis and treatment. Head Neck Oncol, 2009 1 (1 8. None declared.